カスポファンギンの世界市場規模調査・予測：適応症別、流通チャネル別、地域別分析（2023年～2030年）

カスポファンギンの世界市場は2022年に約4億6,278万米ドルと評価され、予測期間2023年～2030年には1.9%以上の健全な成長率で成長すると予測されています。

カスポファンギンはエキノカンジンクラスに属する抗真菌薬です。ある種の真菌による侵襲性真菌症の治療に使用されます。カスポファンギンは、真菌の細胞壁の重要な成分であるβ-（1,3）-D-グルカンの合成を阻害することにより作用します。この薬剤は、成人および小児患者の治療を含む様々な医療現場での使用が承認されています。他の医薬品と同様に、その使用は医学的監督と個々の患者の要因の考慮が必要です。カスポファンギン市場が拡大している背景には、糖尿病やがんなどの慢性疾患の世界の有病率の増加、ヘルスケアインフラへの投資の増加、感染症予防に向けた政府の取り組みや資金の増加といった要因があります。

糖尿病やがんなどの慢性疾患の世界の有病率の増加は、カスポファンギン市場の成長の重要な促進要因として浮上しています。慢性疾患の患者、特に化学療法や臓器移植のような集中的な治療を受けている患者は、免疫システムが低下していることが多いです。この免疫抑制により、日和見真菌感染症に罹患しやすくなります。このような患者では真菌感染症が重症化し、生命を脅かすことがあるため、効果的な治療のためにはカスポファンギンのような強力な抗真菌薬が必要となります。米国心臓協会によると、2020年における糖尿病の世界有病者数は男性2億4,330万人、女性2億2,900万人であり、糖尿病の経済的負担は2015年には1兆3,000億米ドルに達し、2030年には2兆1,000億米ドルから2兆5,000億米ドルに増加すると予測されています。また、国際がん研究機関（IARC）によると、2021年に190万人だったがん患者が、2040年には2,750万人に増加すると推定されています。また、一般市民の真菌感染症に対する意識の高まりや、医薬品開発・技術革新活動の活発化が、市場成長の新たな機会となっています。しかし、カスポファンギンの治療費は高額であるため、2023年～2030年の予測期間を通じて市場の成長は阻害されます。

カスポファンギンの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は2022年に市場を独占しました。カンジダ症や侵襲性アスペルギルス症などの疾患が、特に免疫不全患者や集中治療を受けている患者の間で急増しており、効果的な抗真菌療法の必要性が高まっています。予測期間中、アジア太平洋地域が最も急成長する見込みです。同地域では真菌感染症の罹患率が上昇していることが抗真菌薬の需要増に寄与しており、中でも幅広い真菌病原体に対して有効なカスポファンギンは有力な選択肢となっています。さらに、侵襲性真菌感染症の治療におけるカスポファンギンの特典に関する医療従事者や患者の意識の高まりが、その採用を後押ししています。

本調査の目的は、近年のさまざまなセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界のカスポファンギン市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の発展
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 世界のカスポファンギン市場力学

• カスポファンギン市場の影響分析（2020年～2030年）
  • 市場促進要因
    • 糖尿病やがんなどの慢性疾患の世界の有病率の増加
    • ヘルスケアインフラへの投資の増加
    • 感染症予防に向けた政府の取り組みと資金の増加
  • 市場の課題
    • 高い治療費
  • 市場機会
    • 薬剤開発と技術革新の増加
    • 一般市民の真菌感染症に対する意識の高まり

第4章 世界のカスポファンギン市場の産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 カスポファンギンの世界市場：適応症別

• 市場スナップショット
• カスポファンギンの世界市場：適応症別、実績 - ポテンシャル分析
• カスポファンギンの世界市場：適応症別、推定・予測（2020年～2030年）
• カスポファンギン市場：サブセグメント分析
  • カンジダ症
  • 鵞口瘡
  • その他の適応症

第6章 カスポファンギンの世界市場：流通チャネル別

• 市場スナップショット
• カスポファンギンの世界市場：流通チャネル別、実績 - ポテンシャル分析
• カスポファンギンの世界市場：流通チャネル別、推定・予測（2020年～2030年） li>カスポファンギン市場：サブセグメント分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 カスポファンギンの世界市場：地域別分析

• 主要国
• 主な新興国
• 市場スナップショット：地域別
• 北米
  • 米国
    • 推定・予測：適応症別（2020年～2030年）
    • 推定・予測：流通チャネル別（2020年～2030年）
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東・アフリカ

第8章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Fresenius SE & Co. KGaA（Fresenius Kabi）
    • 主要情報
    • 概要
    • 財務（データの入手可能性による）
    • 製品概要
    • 最近の動向
  • Alvogen Inc.
  • Juno Pharmaceuticals
  • Cipla Inc.
  • Merck & Co., Inc.
  • Athenex, Inc.
  • Sanofi S.A.
  • Stanex Drugs and Private Limited
  • Gland Pharma Limited
  • Sun Pharmaceutical Industries Ltd.

第9章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Caspofungin Market, report scope
• TABLE 2. Global Caspofungin Market estimates & forecasts by Region 2020-2030 (USD Million)
• TABLE 3. Global Caspofungin Market estimates & forecasts by Indication 2020-2030 (USD Million)
• TABLE 4. Global Caspofungin Market estimates & forecasts by Distribution Channel 2020-2030 (USD Million)
• TABLE 5. Global Caspofungin Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 6. Global Caspofungin Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 7. Global Caspofungin Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 8. Global Caspofungin Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 9. Global Caspofungin Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 10. Global Caspofungin Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 11. Global Caspofungin Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 12. Global Caspofungin Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 13. Global Caspofungin Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 14. Global Caspofungin Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 15. U.S. Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 16. U.S. Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 17. U.S. Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 18. Canada Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 19. Canada Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 20. Canada Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 21. UK Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 22. UK Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 23. UK Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 24. Germany Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 25. Germany Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 26. Germany Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 27. France Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 28. France Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 29. France Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 30. Italy Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 31. Italy Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 32. Italy Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 33. Spain Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 34. Spain Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 35. Spain Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 36. RoE Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 37. RoE Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 38. RoE Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 39. China Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 40. China Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 41. China Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 42. India Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 43. India Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 44. India Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 45. Japan Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 46. Japan Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 47. Japan Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 48. South Korea Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 49. South Korea Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 50. South Korea Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 51. Australia Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 52. Australia Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 53. Australia Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 54. RoAPAC Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 55. RoAPAC Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 56. RoAPAC Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 57. Brazil Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 58. Brazil Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 59. Brazil Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 60. Mexico Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 61. Mexico Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 62. Mexico Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 63. RoLA Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 64. RoLA Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 65. RoLA Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 66. Saudi Arabia Caspofungin Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 67. South Africa Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 68. RoMEA Caspofungin Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 69. List of secondary sources, used in the study of global Caspofungin Market
• TABLE 70. List of primary sources, used in the study of global Caspofungin Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Caspofungin Market, research methodology
• FIG 2. Global Caspofungin Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Caspofungin Market, key trends 2022
• FIG 5. Global Caspofungin Market, growth prospects 2023-2030
• FIG 6. Global Caspofungin Market, porters 5 force model
• FIG 7. Global Caspofungin Market, pest analysis
• FIG 8. Global Caspofungin Market, value chain analysis
• FIG 9. Global Caspofungin Market by segment, 2020 & 2030 (USD Million)
• FIG 10. Global Caspofungin Market by segment, 2020 & 2030 (USD Million)
• FIG 11. Global Caspofungin Market by segment, 2020 & 2030 (USD Million)
• FIG 12. Global Caspofungin Market by segment, 2020 & 2030 (USD Million)
• FIG 13. Global Caspofungin Market by segment, 2020 & 2030 (USD Million)
• FIG 14. Global Caspofungin Market, regional snapshot 2020 & 2030
• FIG 15. North America Caspofungin Market 2020 & 2030 (USD Million)
• FIG 16. Europe Caspofungin Market 2020 & 2030 (USD Million)
• FIG 17. Asia pacific Caspofungin Market 2020 & 2030 (USD Million)
• FIG 18. Latin America Caspofungin Market 2020 & 2030 (USD Million)
• FIG 19. Middle East & Africa Caspofungin Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Caspofungin Market is valued at approximately USD 462.78 Million in 2022 and is anticipated to grow with a healthy growth rate of more than 1.9% over the forecast period 2023-2030. Caspofungin is an antifungal medication that belongs to the echinocandin class of drugs. It is used in the treatment of invasive fungal infections caused by certain types of fungi. Caspofungin works by inhibiting the synthesis of beta-(1,3)-D-glucan, a critical component of the fungal cell wall. The drug has been approved for use in various medical settings, including treatment in adults and pediatric patients. As with any medication, its use is subject to medical supervision and consideration of individual patient factors. The Caspofungin Market is expanding because of factors such as the increasing global prevalence of chronic disorders such as diabetes and cancer, rising investment in healthcare infrastructure and increasing government initiatives and funding towards preventing infectious diseases.

The increasing global prevalence of chronic disorders, such as diabetes and cancer, has emerged as a significant driver for the growth of the Caspofungin Market. Patients with chronic conditions, especially those undergoing intensive treatments such as chemotherapy or organ transplantation, often experience compromised immune systems. This immunosuppression makes them highly susceptible to opportunistic fungal infections. Fungal infections can be severe and life-threatening in these individuals, necessitating potent antifungal medications such as Caspofungin for effective treatment. According to the American Heart Association, In 2020, the global prevalence of diabetes was 243.3 million males and 229.0 million females, while the economic burden of diabetes amounted to USD 1.3 trillion in 2015, projected to rise to USD 2..1 to USD 2..5 trillion by 2030. Moreover, according to the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is 27.5 million new cases by 2040 from 1.9 million new cases in the year 2021. In addition, increasing awareness about fungal infections among the public and increasing drug development and innovation activities are creating new opportunities to market growth. However, the high cost of Caspofungin treatment stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Caspofungin Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. The prevalence of conditions such as candidiasis and invasive aspergillosis has surged, particularly among immunocompromised patients and those undergoing intensive medical treatments, fueling the need for effective antifungal therapies. Asia Pacific is expected to grow at the fastest over the forecast period. The rising incidence of fungal infections in the region is contributing to an increased demand for antifungal medications, with Caspofungin being a prominent choice due to its effectiveness against a broad spectrum of fungal pathogens. Additionally, the growing awareness among healthcare professionals and patients about the benefits of Caspofungin in treating invasive fungal infections is fueling its adoption.

Major market player included in this report are:

• Fresenius SE & Co. KGaA (Fresenius Kabi)
• Alvogen Inc.
• Juno Pharmaceuticals
• Cipla Inc.
• Merck & Co., Inc.
• Athenex, Inc.
• Sanofi S.A.
• Stanex Drugs and Private Limited
• Gland Pharma Limited
• Sun Pharmaceutical Industries Ltd.

Recent Developments in the Market:

• In March 2023, Cidara Therapeutics and Melinta Therapeutics received approval from the U.S. Food and Drug Administration (FDA) for Rezayyo, an injectable form of rezafungin. This approval signifies its effectiveness in managing candidemia and severe candidiasis.
• In April 2022, Mundipharma and Cidara Therapeutics, Inc. released findings from the Phase 3 ReSTORE clinical trial evaluating rezafungin for the treatment of candidemia and/or invasive candidiasis. The results indicate a favorable efficacy and safety profile for rezafungin.

Global Caspofungin Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Indication, Distribution Channel, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Indication:

• Candidiasis
• Thrush
• Other Indications

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1. Caspofungin Market, by Region, 2020-2030 (USD Million)
  • 1.2.2. Caspofungin Market, by Indication, 2020-2030 (USD Million)
  • 1.2.3. Caspofungin Market, by Distribution Channel, 2020-2030 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Caspofungin Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Caspofungin Market Dynamics

• 3.1. Caspofungin Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing Global Prevalence of Chronic Disorders like Diabetes and Cancer
    • 3.1.1.2. Rising investment in Healthcare Infrastructure
    • 3.1.1.3. Increasing Government Initiatives and Funding towards preventing infectious diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Treatment
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing Drug Development and Innovation
    • 3.1.3.2. Increasing awareness about fungal infections among public

Chapter 4. Global Caspofungin Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Caspofungin Market, by Indication

• 5.1. Market Snapshot
• 5.2. Global Caspofungin Market by Indication, Performance - Potential Analysis
• 5.3. Global Caspofungin Market Estimates & Forecasts by Indication 2020-2030 (USD Million)
• 5.4. Caspofungin Market, Sub Segment Analysis
  • 5.4.1. Candidiasis
  • 5.4.2. Thrush
  • 5.4.3. Other Indications

Chapter 6. Global Caspofungin Market, by Distribution Channel

• 6.1. Market Snapshot
• 6.2. Global Caspofungin Market by Distribution Channel, Performance - Potential Analysis
• 6.3. Global Caspofungin Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Million)
• 6.4. Caspofungin Market, Sub Segment Analysis
  • 6.4.1. Hospital Pharmacies
  • 6.4.2. Retail Pharmacies
  • 6.4.3. Online Pharmacies

Chapter 7. Global Caspofungin Market, Regional Analysis

• 7.1. Top Leading Countries
• 7.2. Top Emerging Countries
• 7.3. Caspofungin Market, Regional Market Snapshot
• 7.4. North America Caspofungin Market
  • 7.4.1. U.S. Caspofungin Market
    • 7.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
    • 7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
  • 7.4.2. Canada Caspofungin Market
• 7.5. Europe Caspofungin Market Snapshot
  • 7.5.1. U.K. Caspofungin Market
  • 7.5.2. Germany Caspofungin Market
  • 7.5.3. France Caspofungin Market
  • 7.5.4. Spain Caspofungin Market
  • 7.5.5. Italy Caspofungin Market
  • 7.5.6. Rest of Europe Caspofungin Market
• 7.6. Asia-Pacific Caspofungin Market Snapshot
  • 7.6.1. China Caspofungin Market
  • 7.6.2. India Caspofungin Market
  • 7.6.3. Japan Caspofungin Market
  • 7.6.4. Australia Caspofungin Market
  • 7.6.5. South Korea Caspofungin Market
  • 7.6.6. Rest of Asia Pacific Caspofungin Market
• 7.7. Latin America Caspofungin Market Snapshot
  • 7.7.1. Brazil Caspofungin Market
  • 7.7.2. Mexico Caspofungin Market
• 7.8. Middle East & Africa Caspofungin Market
  • 7.8.1. Saudi Arabia Caspofungin Market
  • 7.8.2. South Africa Caspofungin Market
  • 7.8.3. Rest of Middle East & Africa Caspofungin Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
  • 8.1.1. Company 1
  • 8.1.2. Company 2
  • 8.1.3. Company 3
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Fresenius SE & Co. KGaA (Fresenius Kabi)
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Recent Developments
  • 8.3.2. Alvogen Inc.
  • 8.3.3. Juno Pharmaceuticals
  • 8.3.4. Cipla Inc.
  • 8.3.5. Merck & Co., Inc.
  • 8.3.6. Athenex, Inc.
  • 8.3.7. Sanofi S.A.
  • 8.3.8. Stanex Drugs and Private Limited
  • 8.3.9. Gland Pharma Limited
  • 8.3.10. Sun Pharmaceutical Industries Ltd.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption